4//SEC Filing
Ullman Anders 4
Accession 0001104659-21-061812
CIK 0001657312other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:07 PM ET
Size
5.7 KB
Accession
0001104659-21-061812
Insider Transaction Report
Form 4
Ullman Anders
Director
Transactions
- Sale
Ordinary Shares
2021-05-04$0.84/sh−12,056$10,123→ 334,856 total
Footnotes (4)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of Restricted Stock Units.
- [F3]The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $0.8063 to $0.8525. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.
- [F4]Consists of 334,856 Ordinary Shares represented by 41,857 ADSs.
Documents
Issuer
Verona Pharma plc
CIK 0001657312
Entity typeother
Related Parties
1- filerCIK 0001836816
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:07 PM ET
- Size
- 5.7 KB